EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Recruiting · NCT06249945 · Registry updated 2024-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2024-12-16 | NCT06249945 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Taiwan University Hospital | 540 |
| Shin Kong Wu Ho-Su Memorial Hospital | 22 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital Hsinchu Branch | Hsinchu | Taiwan | 1 |
| Shin Kong Wu Ho-Su Memorial Hospital | Taipei | Taiwan | 9 |